2,565
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: in-vitro optimization and ex-vivo assessment

, &
Pages 642-654 | Received 04 Feb 2021, Accepted 08 Mar 2021, Published online: 31 Mar 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.